SI9300097B - (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines - Google Patents

(benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines Download PDF

Info

Publication number
SI9300097B
SI9300097B SI9300097A SI9300097A SI9300097B SI 9300097 B SI9300097 B SI 9300097B SI 9300097 A SI9300097 A SI 9300097A SI 9300097 A SI9300097 A SI 9300097A SI 9300097 B SI9300097 B SI 9300097B
Authority
SI
Slovenia
Prior art keywords
formula
alkyl
hydrogen
alk1
amino
Prior art date
Application number
SI9300097A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9300097A (en
Inventor
Rosalia Eugene Van Lommen Guy
Frans Leopold De Bruyn Marcel
Jacobus Joseph Janssens Walter
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SI9300097A publication Critical patent/SI9300097A/sl
Publication of SI9300097B publication Critical patent/SI9300097B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26—Separation; Purification; Stabilisation; Use of additives
    • C07C319/28—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
SI9300097A 1992-02-27 1993-02-02 (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines SI9300097B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84256092A 1992-02-27 1992-02-27

Publications (2)

Publication Number Publication Date
SI9300097A SI9300097A (en) 1993-09-30
SI9300097B true SI9300097B (en) 2001-12-31

Family

ID=25287639

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300097A SI9300097B (en) 1992-02-27 1993-02-02 (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Country Status (37)

Country Link
US (4) US5541180A (cs)
EP (1) EP0639192B1 (cs)
JP (1) JP2779268B2 (cs)
KR (1) KR100190300B1 (cs)
CN (1) CN1038032C (cs)
AP (1) AP416A (cs)
AT (1) ATE138064T1 (cs)
AU (1) AU664237B2 (cs)
BG (1) BG62052B1 (cs)
CA (1) CA2117483C (cs)
CZ (1) CZ282092B6 (cs)
DE (1) DE69302687T2 (cs)
DK (1) DK0639192T3 (cs)
EE (1) EE03029B1 (cs)
ES (1) ES2087721T3 (cs)
FI (1) FI109122B (cs)
GR (1) GR3019927T3 (cs)
HR (1) HRP930235B1 (cs)
HU (2) HU222495B1 (cs)
IL (1) IL104868A (cs)
LT (1) LT3049B (cs)
LV (1) LV10715B (cs)
MX (1) MX9301053A (cs)
MY (1) MY110627A (cs)
NO (1) NO306255B1 (cs)
NZ (1) NZ249124A (cs)
OA (1) OA10095A (cs)
PH (1) PH31295A (cs)
PL (1) PL174736B1 (cs)
RO (1) RO115630B1 (cs)
RU (1) RU2121999C1 (cs)
SG (1) SG47763A1 (cs)
SI (1) SI9300097B (cs)
SK (1) SK280166B6 (cs)
TW (1) TW225531B (cs)
WO (1) WO1993017017A1 (cs)
ZA (1) ZA931404B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ286645B6 (cs) * 1993-08-19 2000-05-17 Janssen Pharmaceutica N.V. Substituované dihydropyranopyridiny jako takové a pro použití v lékařství, způsob a meziprodukty pro jejich výrobu, farmaceutické prostředky na jejich bázi a způsob jejich výroby
ATE256130T1 (de) * 1993-08-19 2003-12-15 Janssen Pharmaceutica Nv Gefässverengende dihydrobenzopyranderivate
PH31437A (en) * 1993-08-27 1998-11-03 Janssen Pharmaceutica Nv Tontophoretic delivery of an antimigrane drug.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
HRP950149A2 (en) * 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
US6054462A (en) * 1994-04-13 2000-04-25 Janssen Pharmaceutica, N.V. Intranasal antimigraine compositions
FR2724383B1 (fr) * 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
EP1123933A1 (en) * 1994-10-14 2001-08-16 MERCK PATENT GmbH 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
KR19990021931A (ko) * 1995-06-08 1999-03-25 디르크 반테 미세구형 전분의 항편두통 조성물
FR2752735B1 (fr) * 1996-09-05 1998-10-02 Synthelabo Utilisation de derives de benzofurane pour obtenir un medicament destine au traitement de l'insuffisance veineuse et de l'ulcere veineux
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
RU2134108C1 (ru) * 1998-10-06 1999-08-10 Заславская Рина Михайловна Средство для лечения артериальной гипертонии, способ лечения артериальной гипертонии
FR2787789B1 (fr) * 1998-12-29 2002-06-14 Lipha Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations
ATE279409T1 (de) 1999-06-02 2004-10-15 Janssen Pharmaceutica Nv Pyrrolidinyl, piperidinyl oder homopiperidinyl substituierte (benzodioxan, benzofuran oder benzopyran) derivate
AU773773B2 (en) * 1999-06-02 2004-06-03 Janssen Pharmaceutica N.V. Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
DE60130677T2 (de) * 2000-11-29 2008-07-17 Eli Lilly And Co., Indianapolis 1-(2-m-methansulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine und ihre akzeptablen pharmazeutischen salze und solvate und ihre verwendung zur behandlung von inkontinenz
CZ20032258A3 (cs) * 2001-02-23 2004-01-14 Merck & Co., Inc. N-substituované nearylové heterocyklické sloučeniny
AU2002355170B2 (en) 2001-07-26 2007-06-07 Merck Patent Gmbh Novel use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
US7618988B2 (en) * 2001-09-19 2009-11-17 Merck Patentgesellschaft Use of substituted aminomethyl chromans
KR20050092795A (ko) * 2003-01-31 2005-09-22 짐머 오르쏘바이올로직스 인코포레이티드 수핵 조직을 함유하는 하이드로젤 조성물
ZA200507112B (en) * 2003-03-31 2007-03-28 Taisho Pharmaceutical Co Ltd Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
EP1464335A3 (en) * 2003-03-31 2007-05-09 Taisho Pharmaceutical Co. Ltd. Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CN105061392B (zh) * 2015-07-20 2017-07-18 上海现代哈森（商丘）药业有限公司 一种硫酸胍生合成方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636238A (cs) * 1962-08-20
FR1366479A (fr) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Procédé de production de nouveaux dérivés de la pipéridine et de leurs sels
FR1366472A (fr) * 1962-09-29 1964-07-10 Glaverbel Dispositif pour la fabrication du verre en feuille
GB1411531A (en) * 1972-10-24 1975-10-29 Lafon Labor Amino derivatives of 1,4-benzodioxan
GR71865B (cs) * 1978-03-20 1983-07-07 Ciba Geigy
US4405922A (en) * 1979-05-23 1983-09-20 Hitachi Koki Company, Limited Failure detection circuit for impact printers or the like
US4405622A (en) * 1980-10-16 1983-09-20 Syntex (U.S.A.) Inc. [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
FR2524887A1 (fr) * 1982-04-08 1983-10-14 Bouchara Emile Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
CA2011899A1 (en) * 1989-03-13 1990-09-13 Masaaki Toda Benzopyran derivatives
WO1994017017A1 (en) * 1991-07-15 1994-08-04 Exxon Research And Engineering Company Benzene removal from gasoline boiling range streams
DE4303657A1 (de) * 1993-02-09 1994-08-11 Bayer Ag Neue Chinolon- und Naphthyridoncarbonsäurederivate

Also Published As

Publication number Publication date
DE69302687T2 (de) 1996-11-14
EE03029B1 (et) 1997-08-15
LV10715A (lv) 1995-06-20
DK0639192T3 (da) 1996-08-19
HRP930235B1 (en) 1999-04-30
AU664237B2 (en) 1995-11-09
KR100190300B1 (ko) 1999-06-01
LTIP367A (lt) 1994-04-25
ZA931404B (en) 1994-08-26
AP9300493A0 (en) 1993-04-30
LV10715B (en) 1995-12-20
ATE138064T1 (de) 1996-06-15
SK102994A3 (en) 1995-07-11
CS202094A3 (en) 1995-01-18
NO306255B1 (no) 1999-10-11
PL174736B1 (pl) 1998-09-30
IL104868A (en) 1998-01-04
WO1993017017A1 (en) 1993-09-02
GR3019927T3 (en) 1996-08-31
US5607949A (en) 1997-03-04
SK280166B6 (sk) 1999-09-10
US5624952A (en) 1997-04-29
BG62052B1 (bg) 1999-01-29
CN1038032C (zh) 1998-04-15
NO943186L (no) 1994-08-29
RO115630B1 (ro) 2000-04-28
SG47763A1 (en) 1998-04-17
HU211742A9 (en) 1995-12-28
DE69302687D1 (de) 1996-06-20
NO943186D0 (no) 1994-08-29
RU94041210A (ru) 1996-07-10
HRP930235A2 (en) 1997-10-31
MX9301053A (es) 1994-03-31
US5688952A (en) 1997-11-18
RU2121999C1 (ru) 1998-11-20
BG98870A (bg) 1995-03-31
FI109122B (fi) 2002-05-31
CZ282092B6 (cs) 1997-05-14
ES2087721T3 (es) 1996-07-16
US5541180A (en) 1996-07-30
HU9402464D0 (en) 1994-10-28
OA10095A (en) 1996-12-18
SI9300097A (en) 1993-09-30
HU222495B1 (hu) 2003-07-28
FI943928A0 (fi) 1994-08-26
AP416A (en) 1995-09-29
AU3499193A (en) 1993-09-13
CA2117483A1 (en) 1993-09-02
PH31295A (en) 1998-07-06
IL104868A0 (en) 1993-06-10
JPH07504408A (ja) 1995-05-18
FI943928A7 (fi) 1994-08-26
LT3049B (en) 1994-10-25
NZ249124A (en) 1995-08-28
HUT71129A (en) 1995-11-28
EP0639192B1 (en) 1996-05-15
CA2117483C (en) 2001-01-09
JP2779268B2 (ja) 1998-07-23
MY110627A (en) 1998-09-30
TW225531B (cs) 1994-06-21
EP0639192A1 (en) 1995-02-22
CN1079470A (zh) 1993-12-15

Similar Documents

Publication Publication Date Title
SI9300097B (en) (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
EA200400615A1 (ru) Производные амидов в качестве ингибиторов гликогенсинтаза-киназы 3-бета
PL325312A1 (en) Methaguanidine, urea, thiourea or azacyclic derivatives of aminobenzoic acid as antagonists of integrin
BR0213790A (pt) Derivados de aminobenzamida como inibidores de glicogênio sintase cinase 3beta
DK1119567T3 (da) Quinazolinderivater
EP0235878A3 (en) Novel compounds
TR199801594A2 (xx) CCR-3 resept�r antagonistleri.
TR200001964T2 (tr) Yeni asilguanidin türevleri
PE20021005A1 (es) Quinazolinas como inhibidores de mmp-13
BR9913947A (pt) Derivado de amida, processo para a preparação do mesmo ou um sal farmaceuticamente aceitável ou éster clivável in vivo deste, uso do mesmo, e, composição farmacêutica
IL106900A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
ID29632A (id) Pembuatan bentuk-bentuk dosis larutan bening berair dengan asam-asam empedu
WO2006010641A3 (en) Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
BR0009083A (pt) Derivado de amida, processo para a preparação de um derivado de amida, composição farmacêutica, uso de um derivado de amida, método de tratamento de doenças ou de condições médicas mediadas por citocinas
CA2131797A1 (en) Condensed indole derivatives as 5ht4-receptor antagonists
CA2225366A1 (en) Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
HUT65351A (en) Process for preparing ethanolamine derivatives haring sympathominetic and anti-pollakiuria activity and pharmaceutical compositions containing them as active agent
MXPA04002495A (es) Compuestos de imidazopiridin como moduladores del receptor 5-ht4.
BR0209452A (pt) Composto de cefem, processo para sua preparação, composição farmacêutica e uso do composto
IL144725A0 (en) Novel guanidine derivatives as inhibitors of cell adhesion
EP0351385A3 (en) New amidino and guanidino derivatives
KR900018047A (ko) 치환된 퀴나졸린 유도체
TR200103856T2 (tr) Naftiridin türevleri, bunların preparasyon işlemleri, kullanımları ve farmasötik kompozisyonlar.
EA200200121A1 (ru) Замещенные производные пурина в качестве ингибиторов клеточной адгезии
MY137083A (en) Non-nucleoside reverse transcriptase inhibitors

Legal Events

Date Code Title Description
IF Valid on the event date